BSR-20123-43427
4 vaccinations
9 coded responses
45 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 551 / MN
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Survey response — days 1–6 daily, dose 1MedDRA: Type 1 diabetes mellitus — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to workFree text: T1d, blood sugars have been normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-22
-
2021-01-27
Survey response — day 14, dose 1MedDRA: Arthralgia — Feeling: GoodFree text: Unclear if associated, but increased shoulder pain (top of joint, kind of above deltoid). Started yesterday, present today. Mild. No known trauma or overuse. No other symptoms like redness, swelling, heat, etc.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Dose 2 — Pfizer-BioNTech
- 2021-02-03
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease, Therapeutic response unexpected — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: T1d, blood sugars have been normal!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
-
2021-03-03
Survey response — day 28, dose 2MedDRA: Fatigue, Stress — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue, likely stress related.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Survey response — day 35, dose 2MedDRA: Headache, Migraine, Sensitivity to weather change — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache, possibly due to change in weather, or migraine..3 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
- 2021-05-05
-
2021-08-04
Survey response — 6 months, dose 2MedDRA: Cough, Ear infection, Eye infection, Respiratory disorder, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Respiratory illness, eye & ear infection around 7/12, still with mild cough. Tested for COVID x2 and negative.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-04
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-08-10
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-16
Dose 3 — Pfizer-BioNTech
- 2021-10-16
-
2021-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-10-19
- 2021-10-20
- 2021-10-21
- 2021-10-22
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
-
2021-11-20
Survey response — day 35, dose 3MedDRA: Diarrhoea, Gastrointestinal disorder, Nausea — Feeling: Fair · Be unable to work or attend schoolFree text: GI illness: nausea, diarrhea. 2-3 days onset Sunday. Resolved. No known exposures, did not get tested for COVID.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-27
- 2022-01-15
- 2022-04-17
-
2022-10-16
Survey response — 12 months, dose 3MedDRA: Alopecia, Amenorrhoea, COVID-19, Fatigue, Sleep disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Covid infection (May), hair loss, lack of menses, sleep problems, excessive fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-18
-
2022-10-27
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-17
Survey response — day 21, dose 4MedDRA: Arthralgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Bilateral hip painMedDRA releases: 2024-11 · check-in free text available
- 2022-11-24
- 2022-12-01
- 2022-12-08
- 2023-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-10-16 | Pfizer-BioNTech | No |
| 4 | 2022-10-27 | Pfizer-BioNTech | Flu |
Call center
3 call center cases
1 successful · 1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): T1d, blood sugars have been normal.
Release 2 — day 14, dose 1
Symptoms: Unclear if associated, but increased shoulder pain (top of joint, kind of above deltoid). Started yesterday, present today. Mild. No known trauma or overuse. No other symptoms like redness, swelling, heat, etc.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): T1d, blood sugars have been normal!
Release 5 — day 28, dose 2
Symptoms: Fatigue, likely stress related.
Release 5 — day 35, dose 2
Symptoms: Headache, possibly due to change in weather, or migraine..3 days
Release 9 — 6 months, dose 2
Symptoms: Respiratory illness, eye & ear infection around 7/12, still with mild cough. Tested for COVID x2 and negative.
Release 10 — day 35, dose 3
Symptoms: GI illness: nausea, diarrhea. 2-3 days onset Sunday. Resolved. No known exposures, did not get tested for COVID.
Release 12 — 12 months, dose 3
Symptoms: Covid infection (May), hair loss, lack of menses, sleep problems, excessive fatigue
Release 12 — day 21, dose 4
Symptoms: Bilateral hip pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | · | · | ✓ |
| SD | Amenorrhoea | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Ear infection | ✓ | · | ✓ |
| SD | Eye infection | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Respiratory disorder | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SD | Sensitivity to weather change | ✓ | ✓ | ✓ |
| SD | Sleep disorder | · | · | ✓ |
| SD | Stress | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Therapeutic response unexpected | ✓ | ✓ | ✓ |
| SRO | Type 1 diabetes mellitus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release